The Thirty Group

Thirty Holdings Limited was established in October 2018 following a corporate restructure.

The Company’s trading name is 30 Technology, derived from the molecular weight of nitric oxide (30).

30 Technology: Unlocking and delivering the promise of therapeutic nitric oxide.

THIRTY HOLDINGS LIMITED HAS SIX WHOLLY OWNED SUBSIDIARIES

Edixomed Limited

Registered in Scotland No.SC363191

Thirty Respiratory Limited

Registered in England No.11677458

Thirty Therapeutics Limited

Registered in England No.11677522

Thirty Pharma Limited

Registered in England No.11678196

Thirty Dermatology Limited

Registered in England No.11677253

Thirty Animal Health Limited

Registered in England No.11677262

Edixomed Limited

Registered in Scotland No.SC363191

Thirty Respiratory Limited

Registered in England No.11677458

Thirty Therapeutics Limited

Registered in England No.11677522

Thirty Pharma Limited

Registered in England No.11678196

Thirty Dermatology Limited

Registered in England No.11677253

Thirty Animal Health Limited

Registered in England No.11677262

30 TECHNOLOGY is developing and defining new models of care to treat many serious medical conditions by enhancing the body’s healing and defence mechanisms.

30 TECHNOLOGY Therapeutic Nitric Oxide